↓ Skip to main content

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer

Overview of attention for article published in Breast Cancer Research, July 2012
Altmetric Badge

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
50 Mendeley